A2 Refereed review article in a scientific journal
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Authors: Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JA, Cilia R, Ballanger B, Niethammer M, Stoessl JA
Publisher: WILEY
Publication year: 2017
Journal: Movement Disorders
Journal name in source: MOVEMENT DISORDERS
Journal acronym: MOVEMENT DISORD
Volume: 32
Issue: 2
First page : 181
Last page: 192
Number of pages: 12
ISSN: 0885-3185
eISSN: 1531-8257
DOI: https://doi.org/10.1002/mds.26907
Abstract
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. (c) 2016 International Parkinson and Movement Disorder Society.
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. (c) 2016 International Parkinson and Movement Disorder Society.
UTU Research Portal